NCT01855880 - Phase IIa Study of Multiple Doses of AbGn-168H by iv Infusion in Moderate to Severe Chronic Plaque Psoriasis Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

March 31, 2014

Conditions

Moderate to Severe Chronic Plaque Psoriasis

Interventions

BIOLOGICAL

AbGn-168H

BIOLOGICAL

placebo

Trial Locations (15)

10016

University Urology Associates & Manhattan Research Associates, New York

10029

Mount Sinai School of Medicine, New York

23233

West End Dermatology Assotiate, Richmond

29650

Radiant Research, Inc., Greer

32127

Progressive Medical Research, Orange

33472

Visions Clinical Research, Boynton Beach

33609

Olympian Clinical Research, Tampa

34471

Renstar Medical Research, Ocala

46202

Indiana University Dermatology, Indianapolis

46256

DawesFretzin Clinical Research Group, LLC., Indianaopoli

72205

Baptist Health Certer for Clinical Research, Little Rock

72758

Northwest AR Clinical Trials, Rogers

73112

Research Affiliation, Oklahoma City

77056

Suzanne Bruce and Associates, The Center for Skin Research, Huston

08009

Comprehensive Clinical Research, Berlin

All Listed Sponsors

lead

AbGenomics B.V Taiwan Branch

INDUSTRY